RICT 2018
Conferences > Archives > RICT 2018

Confirmed Speakers


Plenary Speakers

PL09 - Paul Ehrlich Award Lecture - Chemical Biology on the Genome
Prof. Sir Shankar BALASUBRAMANIANProf. Sir Shankar BALASUBRAMANIAN
(UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)

Read more
PL17 - Nanoparticle-based Strategies in Oncology
Prof. Jean-Pierre BENOITProf. Jean-Pierre BENOIT
(UNIVERSITY OF ANGERS, Angers, France)

Read more
PL22 - Two Adventures in Chemical Biology - in vivo Chemistry and Real-time Optical Medical Imaging
Prof. Mark BRADLEYProf. Mark BRADLEY
(UNIVERSITY OF EDINBURGH, Edinburgh, United Kingdom)

Read more
PL01 - Disrupting Cancer Care & Outcomes by Putting Patients in the Driving Seat
Dr Anne BRUINVELSDr Anne BRUINVELS
(PX HEALTHCARE, London, United Kingdom)

Read more
PL21 - Pierre Fabre Award lecture
PROTAC-mediated Protein Degradation: A New Therapeutic Modality
Prof. Craig CREWSProf. Craig CREWS
(UNIVERSITY OF YALE, New Haven, United States)

Read more
PL04 - Ghrelin Receptor Ligands: from the Bench to the Drug on the Market
Dr Jean-Alain FEHRENTZDr Jean-Alain FEHRENTZ
(CNRS-UNIVERSITY OF MONTPELLIER, Montpellier, France)

Read more
PL11 - Identification of Chemokine Neutraligands Targeting Atopic Diseases and Hyperalgesia
Dr Jean-Luc GALZIDr Jean-Luc GALZI
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)

Read more
PL10 - Ancient and Modern Scaffolds for Biologically Active Chemical Space
Prof. Arasu GANESANProf. Arasu GANESAN
(UNIVERSITY OF EAST ANGLIA, Norwich, United Kingdom)

Read more
PL06 - Structure-guided Development of Selective GPCR Ligands
Prof. Peter GMEINERProf. Peter GMEINER
(FRIEDRICH ALEXANDER UNIVERSITY, Erlangen, Germany)

Read more
PL07 - Late Stage Fluorination for Medicine
Prof. Véronique GOUVERNEURProf. Véronique GOUVERNEUR
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)

Read more
PL15 - Identifying Inter-Helical Interactions Involved in GPCR Structure-Function and the Forces that Determine Receptor-Ligand Residence Time
Dr Alexander HEIFETZDr Alexander HEIFETZ
(EVOTEC, Abingdon, United Kingdom)

Read more
PL05 - Structure-Based Drug Discovery for G Protein-Coupled Purine Receptors
Prof. Kenneth A. JACOBSONProf. Kenneth A. JACOBSON
(NIDDK, Bethesda, United States)

Read more
PL19 - Chemical Tools to Probe Reversible Lysine Acetylation
Prof. Manfred JUNGProf. Manfred JUNG
(ALBERT LUDWIGS UNIVERSITY OF FREIBURG, Freiburg, Germany)

Read more
PL14 - Pharmacophore-based Analysis of Molecular Dynamics Trajectories: Towards Understanding KD of Protein Ligands
Prof. Thierry LANGERProf. Thierry LANGER
(UNIVERSITY OF VIENNA, Vienna, Austria)

Read more
PL13 - Potential Therapeutic Targets in the Brain Renin-Agiotensin and Apelinergic Systems for Treatment of Cardiovascular Diseases
Dr Catherine  LLORENS-CORTESDr Catherine LLORENS-CORTES
(INSERM/COLLÈGE DE FRANCE, Paris, France)

Read more
PL18 - Chemistry as the Helping Tool to Develop New Therapeutic Strategies
Prof. Maria Luz LOPEZ RODRIGUEZProf. Maria Luz LOPEZ RODRIGUEZ
(COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain)

Read more
PL20 - The Confobody Technology, a New Platform to Enable Fragment Screening on GPCRs
Dr Christel MENETDr Christel MENET
(CONFO THERAPEUTICS, Brussels, Belgium)

Read more
PL02 - Chemogenetic Approachs to Validate Poorly Characterised GPCRS
Prof. Graeme MILLIGANProf. Graeme MILLIGAN
(UNIVERSITY OF GLASGOW, Glasgow, United Kingdom)

Read more
PL08 - Single Electron Processes Enabling Organic Synthesis
Prof. Gary A. MOLANDERProf. Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)

Read more
PL12 - Discovery of Foliglurax, an mGluR4 PAM for the Treatment of Parkinson’s Disease
Dr Stephan SCHANNDr Stephan SCHANN
(DOMAIN THERAPEUTICS SA, Illkirch, France)

Read more
PL03 - Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism
Dr Patrick SCHNIDERDr Patrick SCHNIDER
(ROCHE PHARMACEUTICAL, Basel, Switzerland)

Read more
PL23 - Therapeutic In Vivo Synthetic Chemistry
Prof. Nori TANAKAProf. Nori TANAKA
(RIKEN, Saitama, Japan)

Read more
PL16 - Cellular Delivery and Oral Uptake of Cyclic Peptides
Dr Thomas  VORHERRDr Thomas VORHERR
(NOVARTIS, Basel, Switzerland)

Read more

Keynote Speakers

KL05 - Topical Intestinal Agonists of the Bile Acid Receptor TGR5: Controlling Target Engagement by Innovative Molecular Engineering
Dr Julie CHARTONDr Julie CHARTON
(UNIVERSITY OF LILLE, INSTITUT PASTEUR DE LILLE, Lille, France)

Read more
KL06 - Drug-target Residence Time – a Misleading Concept
Dr Rutger FOLMERDr Rutger FOLMER
(MERCACHEM, Nijmegen, The Netherlands)

Read more
KL04 - Inducible Chemical-genetic Fluorescent Markers for Bioimaging
Dr Arnaud GAUTIERDr Arnaud GAUTIER
(ECOLE NORMALE SUPÉRIEURE, Paris, France)

Read more
KL02 - Discovery of New Brain Penetrating Neuropeptide S Receptor (NPSR) Antagonists
Dr Julien POTHIERDr Julien POTHIER
(IDORSIA PHARMACEUTICALS LTD., Allschwil, Switzerland)

Read more
KL01 - Discovery of The Clinical Candidate Ribuvaptan, a Dual Acting Vasopressin V1a/V2 Receptor Antagonist for the Treatment of Heart Failure
Dr Carsten SCHMECKDr Carsten SCHMECK
(BAYER, Wuppertal, Germany)

Read more
KL03 - Dye-loaded Lipid Nanoparticles: Contrast Agents for Image-guided Surgery and Tools for Drug Delivery
Dr Isabelle TEXIERDr Isabelle TEXIER
(LETI-HEALTH, Grenoble, France)

Read more

Organised by

EFMC Sponsored Event

Supported by

Media Partners

Copyright 2018 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys